Atossa Therapeutics Inc (ATOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,083 | 4,443 | 1,246 | 3,158 | 3,991 |
| Other current assets | 0 | 0 | 0 | 0 | 111 |
| TOTAL | $3,255 | $4,564 | $1,455 | $3,386 | $4,295 |
| Non-Current Assets | |||||
| PPE Net | 55 | 85 | 114 | 146 | 172 |
| Intangibles | 640 | 1,402 | 1,447 | 1,492 | 1,701 |
| Other Non-Current Assets | 194 | 228 | 268 | 76 | 76 |
| TOTAL | $890 | $1,714 | $1,830 | $1,714 | $1,949 |
| Total Assets | $4,144 | $6,278 | $3,285 | $5,100 | $6,243 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 254 | 197 | 283 | 429 | 814 |
| Accrued Expenses | 17 | 13 | 76 | 169 | 464 |
| Other current liabilities | 776 | 654 | 516 | 729 | 1,224 |
| TOTAL | $1,047 | $864 | $874 | $1,327 | $2,502 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,047 | $864 | $874 | $1,327 | $2,502 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 315 | 316 | 220 | 216 | 216 |
| Common Shares | 57 | 57 | 40 | 39 | 33 |
| Retained earnings | -57,304 | -54,780 | -54,985 | -53,262 | -50,935 |
| TOTAL | $3,097 | $5,415 | $2,410 | $3,773 | $3,742 |
| Total Liabilities And Equity | $4,144 | $6,278 | $3,285 | $5,100 | $6,243 |